Know Cancer

or
forgot password

Lymphoma Follow-up Protocol


N/A
21 Years
N/A
Open (Enrolling)
Both
Lymphoma

Thank you

Trial Information

Lymphoma Follow-up Protocol


The intent of this protocol is to accrue up to 800 volunteers who are interested in
participating in NIA research studies as part of follow-up for previous cancer treatment at
NIH. Participants will be asked to answer questions regarding their general health status,
diagnoses, and admissions to hospital, and to provide possible documentation. They may be
asked to come to the NIA Clinical Research Unit at Harbor Hospital to participate in a
follow-up evaluation. They will have the opportunity to obtain additional information about
studies in which they may wish to participate and to discuss eligibility issues with NIA
staff members. Any identified clinical problems in need of care will also be discussed.
Volunteers may be referred, with their permission, to their private medical doctor for
follow-up. They may be re-evaluated within a year for further follow-up.

The follow-up evaluation may include history and physical, blood and urine tests,
questionnaire, MRI or CT.


Inclusion Criteria:



- Previously treated on an approved NCI/NIH protocols

- Willing and able to provide informed consent for current NIA protocol

- Rare, unusual, interesting or unknown condition that requires diagnosis

Exclusion Criteria:

- Does not meet the criteria of any previously-approved NIH Protocol.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Long-term survival following treatment for lymphoma

Outcome Time Frame:

Annually

Safety Issue:

No

Principal Investigator

Patricia L. Duffey, RN

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Institute on Aging (NIA)

Authority:

United States: Federal Government

Study ID:

AG0108; 03-AG-N337

NCT ID:

NCT00744120

Start Date:

October 2003

Completion Date:

December 2013

Related Keywords:

  • Lymphoma
  • cancer
  • Lymphoma

Name

Location

NIA Clinical Research UnitBaltimore, Maryland  21225